Terra Tech Insiders Cash Out As Cannabis Penny Stock Enrichment Scheme Unfolds

Editor’s Note: We published a follow-up to this article on 8/31 in response to the company’s SEC filing that withdrew the shareholder proposal we detailed in this article.

Investing in U.S. publicly-traded cannabis stocks continues to be a hazardous endeavor for the most part. The Cannabis Stock Index has declined by 66% since the end of 2012 despite tremendous progress and growth in the overall cannabis industry.  Measuring from the peak in early 2014, it’s even worse, with the index having lost almost 97% of its value. Quite simply, cannabis stocks, which trade almost entirely on the OTC and not the NYSE or NASDAQ, are more often about penny stocks than about cannabis.

There are a handful of companies that have been around since 2012, and most of them have failed to advance anything but the number of shares outstanding and the number of silly press releases.  One exception has been Terra Tech (OTC: TRTC), the California-based company that recently acquired Blum Oakland and is in the process of opening dispensaries and cultivation and processing facilities in Nevada. More recently, it was able to have an S-3 filing declared effective by the SEC, which is a major accomplishment for any OTC company.

Despite all of the progress, one recent development threatens to derail it. TRTC shareholders are being asked to vote on a proposal on September 26th that would permit the Board of Directors to implement a reverse-split on the common shares and other classes of stock but that would exempt holders of the “B Preferred” shares. B Preferred shares are held by insiders and entitle holders to 5.38 common shares upon conversion and also offer extra voting rights. Here are the holders of the B Preferred:

TRTC B Preferred Holders

The group at the top represents officers and directors of the company, while Salwa Ibrahim and Martin Kaufman, her husband, are part of Blum Oakland, which was acquired earlier this year.

The company first introduced the idea of treating its common shareholders differently than its B Preferred holders in a preliminary proxy filed in April. While many had hoped that this outrageous proposal would be removed from the final proxy, which was filed in August, the potential amendment to the Amended Articles of Incorporation was still included:

TRTC proxy proposals

In order to appreciate the potential impact of the exclusion of the Series B from a reverse-split, it’s important to understand the capital structure of the company.  There are 350mm common shares, but the company has other dilutive securities which could add 429,385,696 additional shares:

  • 30,000,000 shares of Common Stock issuable under the 2016 Equity Incentive Plan;
  • 100 shares of Common Stock issuable upon conversion of our Series A Preferred Stock;
  • 106,890,000 shares of Common Stock issuable upon conversion of our Series Q Preferred Stock, which conversion will occur immediately upon the filing of the Certificate of Amendment with the Secretary of State of the State of Nevada if this Proposal 4 is approved by our stockholders;
  • 215,281,283 shares of Common Stock issuable upon conversion of our Series B Preferred Stock (which includes shares of Common Stock issuable as a result of the conversion of Series Z Preferred Stock into Series B Preferred, and thereafter, into shares of Common Stock);
  • 15,164,262 shares of Series B Preferred Stock issuable upon conversion of our Series Z Preferred Stock, which conversion will occur immediately upon the filing of the Certificate of Amendment with the Secretary of State of the State of Nevada if this Proposal 4 is approved by our stockholders;
  • 2,500,00 shares of Common Stock issuable upon conversion of Series N Preferred Stock, which conversion will occur immediately upon the filing of the Certificate of Amendment with the Secretary of State of the State of Nevada if this Proposal 4 is approved by our stockholders;
  • Up to 30,746,782 shares of Common Stock issuable upon exercise of outstanding warrants;
  • Up to 6,700,000 shares of Common Stock issuable upon exercise of outstanding options; and
  • Up to 22,103,269 shares of Common Stock issuable upon conversion of outstanding notes.

Adding the common shares to the potential common shares upon conversion or exercise of these securities, there would be approximately 779mm shares. The company, if it conducts a reverse-split, would exchange each share of common stock for a smaller number of shares, ranging from as few as 0.05 (1:20) to as many as 0.20 (1:5). At present, the B Preferred shares, including conversion of the Z Preferred, would represent approximately 215mm of the 779mm shares, or 27.6%.

With a 1:5 reverse-split, the 215mm shares would not change, while all other shares would be subject. This would boost the ownership of the B Preferred holders to 65.6%.

In the event the reverse-split were 1:20, the ownership of the company by the B Preferred holders would soar to 88.4%!

There may be some reason that justifies this seemingly self-serving action, but our repeated efforts to learn directly from the company were ignored, leaving us to conclude that the answer is the obvious one: Insider enrichment.

Should we be surprised? Mike Nahass, who serves as Director, Secretary and Treasurer of TRTC, made his motivation very clear five years ago in a fascinating documentary detailing the early days of the company, Marijuana Gold Rush (at 24:05).

I am in it for the money and only the money.

nahass in it for the money

Mike Nahass, Director and Officer at Terra Tech

Just this month, Nahass has cashed out of 800K shares at an average price of $0.3387 ($294,953), with the most recent sales reported this morning. He has had other sales this year as well, including 300K shares at a top-tick price of $0.5884 on 4/18, 100K shares at $0.4825 on 4/15, 150K shares at $.3475 on 4/11, 92,500 shares at $0.3782 on 4/8, 100K shares at $0.404 on 4/7, 200K shares at $0.369 on 4/6 and 400K shares at $0.306 on 4/4. In total, Nahass dumped 2.1425mm shares at an average price of $0.3937, with total proceeds of $843K.

He was awarded 900K options at $0.09 per share on January 8th, just days before the company announced the acquisition of Blum Oakland, though the agreement was actually consummated in late December. Options were awarded at that time to several other executives and directors, including CEO Derek Peterson (1.1mm), CFO Michael James (900K), COO Ken VandeVrede (850K), Director Mike VandeVrede (850K), Director Steve VandeVrede (850K) and Independent Director Steven Ross (800K).

Nahass isn’t alone in selling, though, as other insiders have been unloading common shares as well. Since April 1st, there have been many substantial sales:

  • Amy Almsteier, wife of CEO Peterson and a Director, sold 274,800 shares at $0.2701 on 4/1, 303,427 shares at $0.2953 on 4/4, 226,799 at $0.5626 on 4/19, and 523K at $0.34525 on 7/6.  In total, she sold 1.33mm shares for proceeds of approximately $472K, leaving herself with only 246K common shares and the balance of her exposure in the favored B Preferred (3.575mm shares)
  • CEO Derek Peterson sold 622,697 shares at an average price of $0.3327 on July 8th and 9th, realizing total proceeds of over $207K and leaving himself with 1.4mm common shares and 250K shares of the B Preferred according to the Form 4. He was awarded 550K shares in July 2015 as part of his compensation.
  • CFO Michael James sold 250K at $0.3127 on May 25th, realizing proceeds of over $78K and reducing his ownership to 200K common shares.
  • The three VandeVrede brothers sold a total of 753K shares in April and May

Even the newest Independent Director, Kenneth Krueger, who joined the Board of Directors last November and was awarded 350K shares in January, sold 50K shares this month at $0.35123.

The price action over the past year shows that the stock, while down from it peak in April following all the insider selling, is still way up from before the insiders were awarded options in advance of the Blum Oakland deal announcement.

TRTC 1-year chart 082616

A lot has to happen before the insider enrichment through the reverse-split can actually happen. First, shareholders have to approve the proposal at the annual meeting in late September, but this is a forgone conclusion, as Preferred B shares have 538 votes each, or a total of over 13 billion votes. Then, with the ability to do so, the Board must actually act, and the proposal requires it to do so within a year.  CEO Peterson has repeatedly said that the company would do a reverse-split only in conjunction with a move from the OTC to another exchange, but the Board is not bound by this statement.  In fact, the proxy lists three  rationales:

  • The Board believes that a reverse stock split is the most effective means of increasing the per-share market price of our Common Stock in order to satisfy certain quantitative standards for it to become listed on a securities exchange;
  • The Board believes that a higher per-share market price of our Common Stock could encourage greater investor interest in us and promote greater liquidity for our stockholders; and
  • The Board believes that a reverse stock split is advisable to maintain our financing and capital-raising ability and better position us to continue and/or expand our operations.

The next few months could be exciting for TRTC given the potential legalization in November in the two states in which it has cannabis operations, California and Nevada. Additionally, the company could continue its California acquisition strategy, bringing in San Francisco’s Green Door or another entity. With that said, the insiders are about to push through a shareholder proposal that could significantly boost their economic ownership of the company upon a potential reverse-split at the expense of its outside investors.  Already insiders have been aggressively selling common shares while retaining the privileged B Preferred shares over the past five months. For a company that has made much progress on many fronts, this inexplicable corporate behavior is an insult to Terra Tech’s investors and a cautionary story for any investor in a company that is controlled by insiders.

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Exclusive article by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online communities 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter